Darcy Lewis

When you’re an expert in medical CT imaging, two things are bound to happen, says Peter Noël, PhD, associate professor of Radiology and director of CT Research at the Perelman School of Medicine. One: You develop an insatiable curiosity about the inner workings of all kinds of objects, including those unrelated to your research. And two: Both colleagues and complete strangers will ask for your help in imaging a wide variety of unexpected items.

Cemented implant fixation is still the predominant approach among knee replacement surgeons, but the adoption of cementless knees is gaining ground. The technique is currently used in about 20% of primary total knee replacements, according to the American Joint Replacement Registry (AJRR), and that rate is expected to increase over the next decade.

Many people with multiple sclerosis (MS) expect to cope with physical challenges like problems with walking or seeing, but the disease's central nervous system damage often causes mental health symptoms, too.

Cognitive impairment is a recognized sequela of the demyelinating disorder multiple sclerosis (MS). Various studies have attempted to quantify the percentage of patients with cognitive impairment in each MS phenotype. In general, half of all people with MS will experience cognitive symptoms due to the disease, and cognitive decline is more common in the progressive phenotypes.

Have your health care providers asked if you need help with necessities like transportation or housing? Organizations that set national quality standards for cancer care say they should.
Research has increasingly documented the impact of social needs on health and cancer outcomes. That’s why the Joint Commission, which provides quality and safety accreditation, includes asking patients about their health-related social needs in its standards.

CHICAGO — Endocrinologists should consider ways to refine their in-clinic eye exams for patients with thyroid eye disease, including testing for color vision, visual acuity, pupillary reaction, and resistance to retropulsion and Hertel exophthalmometry, according to a presentation at the American Thyroid Association (ATA) 2024 Meeting.
The lack of a Hertel exophthalmometer may be the biggest obstacle to optimal endocrine-based eye care, said endocrinologist Chrysoula Dosiou, MD, of Stanford...

CHICAGO — Endocrinologists may be shifting toward greater use of antithyroid drugs (ATDs) over radioactive iodine (RAI) for initial treatment of Graves’ disease. Severe thyrotoxicosis remains rare but is challenging to treat. And investigational agents like batoclimab and K1-70 hold promise for the future of hyperthyroidism management. These are a few takeaways from a clinical session at the American Thyroid Association (ATA) 2024 Meeting.

People who have progressive, gradual onset of neurologic symptoms over time have primary progressive (PP) MS. In PPMS, the symptoms typically worsen steadily over time and physical and/or cognitive disability accumulates. This represents about 10-15% of people with MS. Here's what you need to know.

For many of us, family planning includes a host of questions, from when to have a family to how many children to have. For some, that list of questions also includes: Are there health limitations that might prevent us from having a family—and if so what help is available to help us achieve our goal? And for those who face life-changing health events, the need to answer such questions may come sooner rather than later—if they want to preserve the option of having biological children in the future.

About 55 percent of the Americans who receive treatment for cancer do so in the community oncology setting, according to the nonprofit Community Oncology Alliance. Patients consistently indicate that they value the option of receiving cancer care in their own communities and that they have a high level of trust in their local physicians. While that has stayed consistent, the definition of community oncology, and engaging with this important group, has not, explained Ed Andreozzi.

About 10-15% of patients with the demyelinating disorder multiple sclerosis (MS) have the primary progressive (PP) form of the disease, which is characterized by a phenotype of gradual progression from onset. PPMS typically includes a steady loss of function from the onset of symptoms. Given that disability progression is essential for a diagnosis of PPMS, physicians seek telltale signs that help them differentiate among the different forms of MS. There is currently only one FDA-approved DMT to treat PPMS: ocrelizumab, a humanized anti-CD20 monoclonal antibody.

If you or your child has ever wished for a safer, more inclusive way to play football, a solution may be coming soon to a playing field near you. If it’s not already there, that is.
Girls flag football — a sport whose time has come.
And Aaron Mares, MD, a primary care sports medicine physician with UPMC Sports Medicine, couldn’t be happier.

Doctors have traditionally used a "step-up," also known as the "escalation," approach for treating multiple sclerosis (MS), the neurodegenerative disease that affects the central nervous system. Using this approach, neurologists often prescribe a first-line therapy that is less effective, but is perceived to be safer. Then, if new MS symptoms consistent with an MS relapse occur or an MRI reveals new damage to the brain or spinal cord, treatment is ramped up to a more effective medication.

Over time, the traditional MS treatment paradigm seems to be less entrenched as international treatment guidelines continue to vary on their recommendations for using specific DMTs. Data from a wide variety of clinical studies have shown that newer, higher-efficacy DMTs can have a positive long-term impact when started earlier in the disease course. As a result, many clinicians have shifted to a so-called "early aggressive" treatment approach in which they initially start patients on a higher-efficacy DMT.